3P se ocupará de la fabricación cGMP de Isunakinra, un medicamento contra tumores sólidos, que se encuentra en fase I/II de desarrollo en pacientes en EEUU
Read moreIndustry trends in the replacement of in-vivo models
Read moreEl objetivo de este ensayo clínico de fase I-IIa es evaluar la seguridad del tratamiento con Omomyc (OMO-103) en humanos y comprobar si se consiguen los mismos resultados que en modelos animales, en ...
Read moreThe first study to evaluate how environmental conditions affect the genetic program underlying cellular survival, led by the University of Toronto, involves the collaboration of the Structural Bioinfo...
Read more3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications.
Read moreResearchers from IBEC, in collaboration with an international team, describe the first molecules capable of regulate glycine receptors with light: Glyght and Azo-NZ1. The new molecules are a promising...
Read moreThe Cilastatin project arose thanks to the research carried out by the deceased Dr. Alberto Tejedor, who was Nephrology Service section chief at the Gregorio Marañón General University Hospital and ...
Read moreEl investigador danés analiza en Vacunas: Verdades, mentiras y controversia la historia de varias de ellas —sarampión, gripe y VPH— para criticar las posturas antivacunas pero también las que c...
Read moreAimed at Hospital Pharmacies, a new Telstar solution for applications that use customized operating & monitoring systems
Read moreLa prescripción retardada de antibióticos en infecciones de vías respiratorias altas no complicadas, que consiste en recetarlos para ser usados solo en caso de que la enfermedad empeore al cabo ...
Read moreUn equipo de investigación del Institut de Neurociències de la Universitat Autònoma de Barcelona (INc-UAB) en colaboración con investigadores del CIBER de Salud Mental (CIBERSAM) ha demostrado que...
Read moreVasculitis is a group of rare autoimmune diseases that, until now, have mainly been treated with corticosteroids and other immunosuppressants. Corticosteroids are effective, but they have many potenti...
Read more